{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_10480", "batch_size": 200, "batch_pos": 68, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 2, "answer": "no", "rationale": "The segment uses neutral language ('began', 'modified') and lacks high-potency verbs or metaphors.", "method": "llm_batch", "batch_id": "batch_2_10324", "batch_size": 200, "batch_pos": 53, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 3, "answer": "no", "rationale": "The segment discusses Moderna's research history, which is not a Q3 pattern.", "method": "llm_batch", "batch_id": "batch_3_17932", "batch_size": 200, "batch_pos": 43, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_5688", "batch_size": 200, "batch_pos": 39, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 5, "answer": "no", "rationale": "Lacks explicit calming language or intensified low-risk evaluation.", "method": "llm_batch", "batch_id": "batch_5_12964", "batch_size": 200, "batch_pos": 38, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"hop_idx": 6, "answer": "uncertain", "rationale": "Missing response from batch", "method": "fallback", "batch_id": "batch_6_16708", "batch_size": 200, "batch_pos": 20, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 6, "answer": "no", "rationale": "Segment does not contain a minimiser used with scale contrast.", "method": "llm_batch_retry", "retry": 1, "batch_id": "batch_6_16708_r1", "batch_size": 200, "batch_pos": 20, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_18272", "batch_size": 200, "batch_pos": 17, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 8, "answer": "yes", "rationale": "Describes historical research related to capability ('mRNA vaccine research actually began') without explicit calming language.", "method": "llm_batch", "batch_id": "batch_8_18020", "batch_size": 200, "batch_pos": 175, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
